Stocks: 503 Market Cap: $51.2T S&P 500: 5,954.50 +0.82%
500 500Market
Viatris
VTRS Rank #421 Health Care
$14.71 -1.21%

Key Statistics

Market Cap
$16.98B
Volume (24h)
$145.2M
P/E Ratio
N/A
EPS
N/A
1 Day
-1.21%
7 Day
-8.46%
YTD
+16.75%
Sector
Health Care
S&P 500 Rank
#421
52W Low: $11.07 52W High: $18.94

About Viatris

Viatris is a global healthcare company that develops, manufactures, and markets a diverse portfolio of prescription products, including generic and branded medicines, vaccines, and over-the-counter (OTC) products. The company's product lineup includes a range of therapeutic areas, including cardiovascular, infectious diseases, and oncology, among others. As a leading player in the generic and biosimilar markets, Viatris plays a critical role in increasing access to affordable medicines globally.

Latest News

Loading latest news...

Sector Peers — Health Care

LLY — Lilly (Eli) $1,003.57 -0.41% JNJ — Johnson & Johnson $245.30 -0.59% ABBV — AbbVie $236.19 +1.00% MRK — Merck & Co. $120.28 +0.38% UNH — UnitedHealth Group $291.96 +0.95% AMGN — Amgen $379.27 +0.60% ABT — Abbott Laboratories $113.10 -0.45% TMO — Thermo Fisher Scientific $512.69 +0.90% View all Health Care stocks →

Daily Market Brief

S&P 500 closing prices, top movers, and sector performance — delivered daily.